NASDAQ · Financial Statements
Elevation Oncology, Inc. (ELEV) Financial Statements
$0.37
NASDAQ: ELEV
Market Cap $21.63M
Overview Financials Dividend Elevation Oncology, Inc. most recently reported annual revenue of $0, net profit of $-44.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $0 $0 $0 $0 $0 Operating Profit $-17.0M $-32.0M $-95.0M $-45.0M $-45.0M Net Profit $-17.0M $-32.0M $-95.0M $-46.0M $-44.0M EPS $-0.73 $-1.38 $-4.09 $-1.34 $-0.78 Op Margin — — — — —
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $81.0M $149.0M $94.0M $89.0M $96.0M Total Liabilities $104.0M $9.0M $45.0M $34.0M $36.0M Cash $79.0M $146.0M $46.0M $49.0M $49.0M Borrowings $0 $0 $29.0M $30.0M $31.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-12.0M $-30.0M $-85.0M $-56.0M $-36.0M Investing Cash Flow $0 $0 $-44.0M $12.0M $-8.0M Financing Cash Flow $0 $0 $0 $1.0M $1.0M Net Cash Flow $78.0M $67.0M $-100.0M $3.0M $0 Free Cash Flow $-12.0M $-30.0M $-86.0M $-56.0M $-36.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA -0.08 FCF Yield -168.14% Quick Ratio 21.21 Interest Coverage -11.18 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock